المؤلفون: Han SH; Ph.D. Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Camp SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Chu H; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Collins R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Gillani R; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ricker CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Reardon B; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Moore N; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA., Kofman E; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA., Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Braun D; Center of Molecular and Cellular Oncology, Yale School of Medicine, New Haven, CT, USA., Choueiri TK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., AlDubayan SH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.

المصدر: European urology open science [Eur Urol Open Sci] 2024 Mar 08; Vol. 62, pp. 107-122. Date of Electronic Publication: 2024 Mar 08 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101771568 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-1683 (Electronic) Linking ISSN: 26661683 NLM ISO Abbreviation: Eur Urol Open Sci Subsets: PubMed not MEDLINE

المؤلفون: Al-Jumaan M; College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia., Chu H; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Alsulaiman A; College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia., Camp SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Han S; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Gillani R; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Al Marzooq Y; College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia., Almulhim F; College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia., Vatte C; College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia., Al Nemer A; College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia., Almuhanna A; College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, 02115, USA., Al-Ali A; College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia., AlDubayan SH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. saud_aldubayan@dfci.harvard.edu.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA. saud_aldubayan@dfci.harvard.edu.; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA. saud_aldubayan@dfci.harvard.edu.; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. saud_aldubayan@dfci.harvard.edu.

المصدر: Genome medicine [Genome Med] 2023 Sep 01; Vol. 15 (1), pp. 65. Date of Electronic Publication: 2023 Sep 01.

نوع المنشور: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/genetics, Humans ; Female ; Arabs/genetics ; Breast ; Risk Factors ; Exome

المؤلفون: Doe-Tetteh SA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Camp SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Reales D; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Crowdis J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Noronha AM; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Wolff B; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, New York., Alano T; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, New York., Galle J; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Selcuklu SD; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Viale A; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Socci ND; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York., Liu YL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Tew WP; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Aghajanian C; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Joan and Sanford I. Weill Medical College of Cornell University, New York, New York., Ladanyi M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., He MX; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Harvard Graduate Program in Biophysics, Boston, Massachusetts., AlDubayan SH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Mazor RD; Clinic of Histiocytic Neoplasms, Institute of Hematology, Assuta Medical Center, Tel Aviv, Israel., Shpilberg O; Clinic of Histiocytic Neoplasms, Institute of Hematology, Assuta Medical Center, Tel Aviv, Israel.; Adelson School of Medicine, Ariel University, Ariel, Israel., Hershkovitz-Rokah O; Department of Molecular Biology, Faculty of Natural Sciences, Ariel University, Ariel, Israel.; Translational Research Lab, Assuta Medical Center, Tel Aviv, Israel., Riancho JA; Department of Internal Medicine, Hospital U.M. Valdecilla, University of Cantabria, IDIVAL, Santander, Spain., Hernandez JL; Department of Internal Medicine, Hospital U.M. Valdecilla, University of Cantabria, IDIVAL, Santander, Spain., Gonzalez-Vela MC; Department of Pathology, Hospital U.M. Valdecilla, University of Cantabria, IDIVAL, Santander, Spain., Buthorn JJ; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Wilson M; Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York., Webber AE; Bioinformatics Core, Memorial Sloan Kettering Cancer Center, New York, New York., Yabe M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Petrova-Drus K; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Rosenblum M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Durham BH; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Abdel-Wahab O; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York., Berger MF; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Donoghue MTA; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Kung AL; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Glade Bender J; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Shukla NN; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York., Funt SA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Joan and Sanford I. Weill Medical College of Cornell University, New York, New York., Dogan A; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Soslow RA; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Al-Ahmadie H; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Feldman DR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Joan and Sanford I. Weill Medical College of Cornell University, New York, New York., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Diamond EL; Joan and Sanford I. Weill Medical College of Cornell University, New York, New York.; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York., Solit DB; Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Joan and Sanford I. Weill Medical College of Cornell University, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jul 05; Vol. 29 (13), pp. 2445-2455.

نوع المنشور: Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Journal Article; Comment

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms*/drug therapy , Ovarian Neoplasms*/genetics , Neoplasms, Germ Cell and Embryonal*, Humans ; Female ; Mutation ; Genomics ; Exome

المؤلفون: Conway JR, Tewari AK, Camp SY, Han S, Crowdis J, He MX, Nyame YA, AlDubayan SH, Schultz N, Szallasi Z, Pomerantz MM, Freedman ML, Fong L, Nelson PS, Brown M, Salari K, Allen EV

المصدر: BioRxiv : the preprint server for biology [bioRxiv] 2023 Mar 25. Date of Electronic Publication: 2023 Mar 25.

نوع المنشور: Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

المؤلفون: Han S; Ph.D. Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Camp SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Chu H; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Collins R; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA., Gillani R; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA., Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Bakouny Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Ricker CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Reardon B; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Moore N; Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, USA., Kofman E; Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA., Labaki C; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Braun D; Center of Molecular and Cellular Oncology, Yale School of Medicine, New Haven, CT, USA., Choueiri TK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Brigham and Women's Hospital, Boston, MA, USA., AlDubayan SH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA, USA.

المصدر: MedRxiv : the preprint server for health sciences [medRxiv] 2023 Jan 19. Date of Electronic Publication: 2023 Jan 19.

نوع المنشور: Preprint

بيانات الدورية: Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE

المؤلفون: Crowdis J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; These authors contributed equally., Balch S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; These authors contributed equally., Sterlin L; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Count Me In, Cambridge, MA 02142, USA., Thomas BS; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Count Me In, Cambridge, MA 02142, USA., Camp SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., Dunphy M; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Count Me In, Cambridge, MA 02142, USA., Anastasio E; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Count Me In, Cambridge, MA 02142, USA., Shah S; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Count Me In, Cambridge, MA 02142, USA., Damon AL; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Count Me In, Cambridge, MA 02142, USA., Ramos R; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Count Me In, Cambridge, MA 02142, USA., Sosa DM; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Count Me In, Cambridge, MA 02142, USA., Small IK; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Count Me In, Cambridge, MA 02142, USA., Tomson BN; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Count Me In, Cambridge, MA 02142, USA., Nguyen CM; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Count Me In, Cambridge, MA 02142, USA., McGillicuddy M; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Count Me In, Cambridge, MA 02142, USA., Chastain PS; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Count Me In, Cambridge, MA 02142, USA., He MX; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Harvard Graduate Program in Biophysics, Boston, MA 02115, USA., Cheung ATM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; NYU Grossman School of Medicine, New York, NY 10016, USA., Wankowicz S; Biophysics Graduate Program, University of California San Francisco, San Francisco, CA 94143, USA.; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, CA 94143, USA., Tewari AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA., Kim D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA., AlDubayan SH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia., Dowdye A; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Count Me In, Cambridge, MA 02142, USA., Zola B; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Count Me In, Cambridge, MA 02142, USA., Nowak J; Cancer ABCs, Brooklyn, NY 11201, USA., Manarite J; Cancer ABCs, Brooklyn, NY 11201, USA., Gunn IH; Founder, MomVetWifeWidow.Org., Olson B; Global Strategist, Health and Life Sciences, Intel Corp, Patient Advocate, SequenceMe, Santa Clara, CA 95054, USA., Lander ES; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Department of Biology, MIT, Cambridge, MA 02142, USA.; Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA., Painter CA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Count Me In, Cambridge, MA 02142, USA., Wagle N; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Count Me In, Cambridge, MA 02142, USA.; Senior author., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02115, USA.; Senior author.; Lead contact.

المصدر: Cell genomics [Cell Genom] 2022 Sep 14; Vol. 2 (9). Date of Electronic Publication: 2022 Aug 19.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier, Inc Country of Publication: United States NLM ID: 9918284260106676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-979X (Electronic) Linking ISSN: 2666979X NLM ISO Abbreviation: Cell Genom Subsets: PubMed not MEDLINE

المؤلفون: Gillani R; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02215, USA; Boston Children's Hospital, Boston, MA 02115, USA., Camp SY; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, USA., Han S; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Harvard Medical School, Boston, MA 02115, USA., Jones JK; Harvard Medical School, Boston, MA 02115, USA., Chu H; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, USA., O'Brien S; Huntsman Cancer Institute, 2000 Circle of Hope Dr, Room 4246, Salt Lake City, UT 84112, USA., Young EL; Huntsman Cancer Institute, 2000 Circle of Hope Dr, Room 4246, Salt Lake City, UT 84112, USA., Hayes L; Huntsman Cancer Institute, 2000 Circle of Hope Dr, Room 4246, Salt Lake City, UT 84112, USA., Mitchell G; Huntsman Cancer Institute, 2000 Circle of Hope Dr, Room 4246, Salt Lake City, UT 84112, USA., Fowler T; Huntsman Cancer Institute, 2000 Circle of Hope Dr, Room 4246, Salt Lake City, UT 84112, USA., Gusev A; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, 02115 MA, USA., Kamihara J; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02215, USA; Boston Children's Hospital, Boston, MA 02115, USA., Janeway KA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02215, USA; Boston Children's Hospital, Boston, MA 02115, USA., Schiffman JD; Huntsman Cancer Institute, 2000 Circle of Hope Dr, Room 4246, Salt Lake City, UT 84112, USA; Department of Pediatrics, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT 84112, USA; Peel Therapeutics, Inc., Salt Lake City, UT 84108, USA., Crompton BD; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Pediatrics, Harvard Medical School, Boston, MA 02215, USA; Boston Children's Hospital, Boston, MA 02115, USA., AlDubayan SH; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, USA; Division of Genetics, Brigham and Women's Hospital, Boston, MA 02115, USA; College of Medicine, King Saudi Bin Abdulaziz University for Health Sciences, Riyadh 14611, Saudi Arabia. Electronic address: saud_aldubayan@dfci.harvard.edu., Van Allen EM; Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, USA; Center for Cancer Genomics, Dana-Farber Cancer Institute, Boston, MA 02115, USA. Electronic address: eliezerm_vanallen@dfci.harvard.edu.

المصدر: American journal of human genetics [Am J Hum Genet] 2022 Jun 02; Vol. 109 (6), pp. 1026-1037. Date of Electronic Publication: 2022 May 04.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 0370475 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6605 (Electronic) Linking ISSN: 00029297 NLM ISO Abbreviation: Am J Hum Genet Subsets: MEDLINE

مواضيع طبية MeSH: Sarcoma*/genetics , Sarcoma, Ewing*/genetics, Child ; DNA Damage/genetics ; Genetic Predisposition to Disease ; Germ Cells ; Germ-Line Mutation/genetics ; Humans

المؤلفون: Tewari AK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Cheung ATM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Crowdis J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Conway JR; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard Graduate Program in Bioinformatics and Integrative Genomics, Boston, MA 02115, USA., Camp SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Wankowicz SA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Livitz DG; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Park J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Lis RT; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Bosma-Moody A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., He MX; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Harvard Graduate Program in Biophysics, Boston, MA 02115, USA., AlDubayan SH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Division of Genetics, Brigham and Women's Hospital, Boston, MA 02115, USA., Zhang Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., McKay RR; Division of Hematology/Oncology, University of California San Diego, San Diego, CA 92037, USA., Leshchiner I; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA., Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Balk SP; Division of Cancer Biology, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA., Getz G; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA., Taplin ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: mary_taplin@dfci.harvard.edu., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Electronic address: eliezerm_vanallen@dfci.harvard.edu.

المصدر: Cell reports [Cell Rep] 2021 Sep 07; Vol. 36 (10), pp. 109665.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

مواضيع طبية MeSH: Androgen Antagonists/*therapeutic use , Nuclear Proteins/*drug effects , Prostate-Specific Antigen/*drug effects , Prostatic Neoplasms/*drug therapy , Repressor Proteins/*drug effects, Adaptor Proteins, Vesicular Transport ; Antineoplastic Agents, Hormonal/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Humans ; Male ; Neoadjuvant Therapy/methods ; Prostatectomy/methods ; Prostatic Neoplasms/pathology ; Risk

المؤلفون: Colli LM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA; Department of Medical Imaging, Hematology, and Oncology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP 14040-900, Brazil., Jessop L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA., Myers TA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA., Camp SY; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA., Machiela MJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA., Choi J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA., Cunha R; Department of Medical Imaging, Hematology, and Oncology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, SP 14040-900, Brazil; Center for Cancer Research, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA., Onabajo O; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA., Mills GC; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA., Schmid V; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7LF, UK., Brodie SA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA., Delattre O; INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris 75248, France., Mole DR; Nuffield Department of Medicine, University of Oxford, Oxford OX3 7LF, UK., Purdue MP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA., Yu K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA., Brown KM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA., Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD 20850, USA. Electronic address: chanocks@mail.nih.gov.

المصدر: American journal of human genetics [Am J Hum Genet] 2021 Sep 02; Vol. 108 (9), pp. 1590-1610. Date of Electronic Publication: 2021 Aug 13.

نوع المنشور: Journal Article; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 0370475 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6605 (Electronic) Linking ISSN: 00029297 NLM ISO Abbreviation: Am J Hum Genet Subsets: MEDLINE

مواضيع طبية MeSH: Chromosomes, Human, Pair 14* , Genetic Loci*, Carcinoma, Renal Cell/*genetics , DNA-Binding Proteins/*genetics , Kidney Neoplasms/*genetics , STAT3 Transcription Factor/*genetics , Transcription Factors/*genetics, Carcinogenesis/genetics ; Carcinogenesis/immunology ; Carcinogenesis/pathology ; Carcinoma, Renal Cell/immunology ; Carcinoma, Renal Cell/pathology ; Carcinoma, Renal Cell/therapy ; Cell Line, Tumor ; Chromatin/chemistry ; Chromatin/immunology ; Chromatin Assembly and Disassembly/immunology ; Cytokines/genetics ; Cytokines/immunology ; DNA-Binding Proteins/immunology ; Gene Expression Regulation ; Genetic Predisposition to Disease ; Genome, Human ; Genome-Wide Association Study ; High-Throughput Nucleotide Sequencing ; Humans ; Immunotherapy/methods ; Kidney Neoplasms/immunology ; Kidney Neoplasms/pathology ; Kidney Neoplasms/therapy ; Polymorphism, Single Nucleotide ; STAT3 Transcription Factor/immunology ; T-Lymphocytes, Cytotoxic ; Transcription Factors/immunology

المؤلفون: Camp SY; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Kofman E; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Reardon B; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Moore ND; Internal Medicine Residency Program, University of Cincinnati, Cincinnati, OH, USA., Al-Rubaish AM; College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia., Aljumaan M; College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia., Al-Ali AK; College of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia., Van Allen EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA., Taylor-Weiner A; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA. amaro.taylor@gmail.com., AlDubayan SH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. SAUD_ALDUBAYAN@DFCI.HARVARD.EDU.; Cancer Program, The Broad Institute of MIT and Harvard, Cambridge, MA, USA. SAUD_ALDUBAYAN@DFCI.HARVARD.EDU.; Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA. SAUD_ALDUBAYAN@DFCI.HARVARD.EDU.; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia. SAUD_ALDUBAYAN@DFCI.HARVARD.EDU.

المصدر: Genetics in medicine : official journal of the American College of Medical Genetics [Genet Med] 2021 May; Vol. 23 (5), pp. 918-926. Date of Electronic Publication: 2021 Feb 02.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 9815831 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0366 (Electronic) Linking ISSN: 10983600 NLM ISO Abbreviation: Genet Med Subsets: MEDLINE

مواضيع طبية MeSH: Testicular Neoplasms*, Genetic Predisposition to Disease ; Genomics ; Genotype ; Germ Cells ; Humans ; Male ; Pathology, Molecular